Abstract
Comparative assessment of cutaneous pharmacokinetics (cPK) by dermal microdialysis (dMD) appears to be suitable to evaluate the bioequivalence (BE) of topical dermatological drug products applied to the skin (TDDPs). Although dMD studies in the literature have reported inconclusive BE assessments, we have addressed several methodological deficiencies to improve dMD’s capability to assess BE between reference (R) and approved generic (referred to as test (T)) gel and cream products of metronidazole (MTZ). The 90% confidence interval (CI) of the geometric mean ratios for the Ln(AUC0-24) and Ln(Cmax) endpoints was centered within the BE limits of 80–125%. The CIs extended outside this range as the proof-of-principle study was not statistically powered to demonstrate BE (N = 7 rabbits). A power analysis suggests that, with the variability observed in this study, 21 rabbits for the cream and 11 rabbits for the gel would be sufficient to support an evaluation of BE with the 2 probe replicates we used, and only 10 and 5 rabbits would be sufficient to power the study for the cream and gel, respectively, if 4 probe replicates are used for each treatment per rabbit. These results indicate that dMD when properly controlling variables can be used to support BE assessments for TDDPs.
Graphical Abstract
Similar content being viewed by others
Data Availability
The data supporting this study’s findings are available from the corresponding author, GS, upon reasonable request.
References
Yacobi A, Shah VP, Bashaw ED, Benfeldt E, Davit B, Ganes D, et al. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products. Pharm Res. 2014;31(4):837–46. https://doi.org/10.1007/s11095-013-1259-1.
Ramezanli T. Bioequivalence of Topical Products: Scientific Considerations. 4th FDA/PQRI Conference on Advancing Product Quality. 2019.
Raney SG, Luke MC. A new paradigm for topical generic drug products: impact on therapeutic access. 2020. p. 1570–1. https://doi.org/10.1016/j.jaad.2020.01.062.
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global Skin Disease Morbidity and Mortality: an update From the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406–12. https://doi.org/10.1001/jamadermatol.2016.5538.
Davit BM, Chen ML, Conner DP, Haidar SH, Kim S, Lee CH, et al. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration. AAPS J. 2012;14(4):915–24. https://doi.org/10.1208/s12248-012-9406-x.
US-FDA: FY2016 Regulatory Science Report: Topical Dermatological Drug Products. https://www.fda.gov/industry/generic-drug-user-fee-amendments/fy2016-regulatory-science-report-topical-dermatological-drug-products (2017). Accessed October 2020.
Luke MC. Overcoming barriers and improving patient access to topical dermatological drugs. Silver Springs: Topical Dermatological Generic Drug Products; 2017.
Shin SH, Rantou E, Raney SG, Ghosh P, Hassan H, Stinchcomb A. Cutaneous pharmacokinetics of acyclovir cream 5% products: evaluating bioequivalence with an in vitro permeation test and an adaptation of scaled average bioequivalence. Pharm Res. 2020;37(10):1–13.
Kuzma BA, Senemar S, Ramezanli T, Ghosh P, Raney SG, Stagni G. Evaluation of local bioavailability of metronidazole from topical formulations using dermal microdialysis: preliminary study in a Yucatan mini-pig model. Eur J Pharm Sci. 2021;159:105741. https://doi.org/10.1016/j.ejps.2021.105741.
Kuzma BA, Senemar S, Ramezanli T, Ghosh P, Raney SG, Stagni G. The dose-duration effect on cutaneous pharmacokinetics of metronidazole from topical dermatological formulations in Yucatan mini-pigs. Eur J Pharm Biopharm. 2022. https://doi.org/10.1016/j.ejpb.2022.05.001.
Bodenlenz M, Tiffner KI, Raml R, Augustin T, Dragatin C, Birngruber T, et al. Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence. Clin Pharmacokinet. 2017;56(1):91–8. https://doi.org/10.1007/s40262-016-0442-z.
Shukla C, Bashaw ED, Stagni G, Benfeldt E. Applications of dermal microdialysis: a review. J Drug Del Sci Tech. 2014;24(3):259–69.
Benfeldt E, Hansen SH, Volund A, Menne T, Shah VP. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. J Invest Dermatol. 2007;127(1):170–8. https://doi.org/10.1038/sj.jid.5700495.
Au WL, Skinner MF, Benfeldt E, Verbeeck RK, Kanfer I. Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects. Skin Pharmacol Physiol. 2012;25(1):17–24. https://doi.org/10.1159/000330489.
Tettey-Amlalo RN, Kanfer I, Skinner MF, Benfeldt E, Verbeeck RK. Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel. Eur J Pharm Sci. 2009;36(2–3):219–25. https://doi.org/10.1016/j.ejps.2008.09.002.
Wei JC, Edwards GA, Martin DJ, Huang H, Crichton ML, Kendall MA. Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micro-medical device translation: from mice, rats, rabbits, pigs to humans. Sci Rep. 2017;7(1):1–16.
Mangelsdorf S, Vergou T, Sterry W, Lademann J, Patzelt A. Comparative study of hair follicle morphology in eight mammalian species and humans. Skin Res Technol. 2014;20(2):147–54.
Hilal-Dandan R, Brunton LL. Chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, trypanosomiasis, leishmaniasis, and other protozoal infections. Goodman and Gilman’s Manual of Pharmacology and Therapeutics, 2 e. New York: McGraw-Hill Education; 2016.
Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761–70. https://doi.org/10.1016/j.jaad.2014.08.027. (quiz 71-2).
Murthy N. Characterizing the critical quality attributes and in vitro bioavailability of acyclovir and metronidazole topical products. Topical dermatological generic drug products: overcoming barriers to development and improving patient access. FDA Public Workshop, Silver Spring, MD; 2017.
Fda US. Bioanalytical method validation guidance for industry. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine. 2018.
Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser Doppler perfusion imaging. J Invest Dermatol. 1994;102(5):807–11. https://doi.org/10.1111/1523-1747.ep12378630.
Scheller D, Kolb J. The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods. 1991;40(1):31–8. https://doi.org/10.1016/0165-0270(91)90114-f.
Pensado A, Chiu WS, Cordery SF, Rantou E, Bunge AL, Delgado-Charro MB, et al. Stratum corneum sampling to assess bioequivalence between topical acyclovir products. Pharm Res. 2019;36(12):180. https://doi.org/10.1007/s11095-019-2707-3.
Haidar SH, Makhlouf F, Schuirmann DJ, Hyslop T, Davit B, Conner D, et al. Evaluation of a scaling approach for the bioequivalence of highly variable drugs. AAPS J. 2008;10(3):450–4. https://doi.org/10.1208/s12248-008-9053-4.
Zhang Q, Ghosh P, Raney SG, D.C. H, Hassan HE, Stinchcomb AL. Characterization of the cutaneous pharmacokinetics of three metronidazole topical drug products evaluated by an in vitro permeation test (IVPT) with excised human skin. AAPS Annual Meeting. San Diego; 2017.
Wang Y, Wong SL, Sawchuk RJ. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm Res. 1993;10(10):1411–9. https://doi.org/10.1023/a:1018906821725.
Stenken JA. Methods and issues in microdialysis calibration. Anal Chim Acta. 1999;379(3):337–58. https://doi.org/10.1016/s0003-2670(98)00598-4.
Garcia Ortiz P, Hansen SH, Shah VP, Sonne J, Benfeldt E. Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology. Skin Pharmacol Physiol. 2011;24(1):44–53. https://doi.org/10.1159/000320151.
Bodenlenz M, Augustin T, Birngruber T, Tiffner KI, Boulgaropoulos B, Schwingenschuh S, et al. Variability of skin pharmacokinetic data: insights from a topical bioequivalence study using dermal open flow microperfusion. Pharm Res. 2020;37(10):204. https://doi.org/10.1007/s11095-020-02920-x.
Acknowledgements
A great appreciation for the animal technician Cora Kaiser and the students (Mohammed Asif Ali, Andrew Litovsky, Rucha Pathak, Darshil Shah, and Morasa Sheikhy) that helped with the rabbit experiments. In addition, we appreciate the tremendous help from Dr. Kerry Weinberg, Director of Diagnostic Medical Sonography at LIU.
Funding
This project was supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of an award (U01FD005862) totaling $750,000 with 100% funded by FDA/HHS.
Author information
Authors and Affiliations
Contributions
Sharareh Senemar and Benjamin A. Kuzma: conceptualization, methodology, formal analysis, investigation, data curation, writing—review and editing; Tannaz Ramezanli, Priyanka Ghosh, and Sam G. Raney: conceptualization, methodology, formal analysis, writing—review and editing; Elena Rantou: bioequivalence data review analysis; Grazia Stagni: conceptualization, methodology, formal analysis, project administration, funding acquisition, writing—original draft, writing—review and editing.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Disclaimer
The views expressed in this paper do not reflect the official policies of the U.S. Food and Drug Administration or the U.S. Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government.
Additional information
Communicated by M. Alice Maciel Tabosa, Jaimin R. Shah, Sharareh Senemar, and Nisarg Modi.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Senemar, S., Kuzma, B.A., Ramezanli, T. et al. Bioequivalence Evaluation of Topical Metronidazole Products Using Dermal Microdialysis in New Zealand Rabbits. AAPS PharmSciTech 24, 204 (2023). https://doi.org/10.1208/s12249-023-02660-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-023-02660-2